qCT

Infervision is a leading AI medical technology company established in 2016, focusing on improving multidisciplinary services and operations with AI. They offer cutting-edge AI products that support medical professionals in all areas, from disease screening and diagnosis to intervention and treatment, patient management, and medical research. Their solutions include InferRead CT Lung for lung nodule detection from chest CT, InferRead DR Chest for detecting chest abnormalities from chest X-rays, InferRead CT Coronary for identifying coronary artery stenosis in coronary CTA, InferRead CT Stroke for triaging hemorrhage from brain CT, InferRead CT Bone for identifying chest fractures from chest CT, and InferRead CT Pneumonia for identifying and triaging pneumonia from chest CT. Additionally, they offer InferOperate for 3D reconstruction in thoracic, liver, and urological surgeries, InferCare for patient management and image follow-up, and InferScholar as an AI-enabled medical research tool.

Hermia is a sophisticated, vendor-neutral molecular imaging suite designed to unify and streamline clinical workflows across nuclear medicine, PET/SPECT/CT/MR reviewing, and advanced imaging analysis while supporting scanners and DICOM data from any manufacturer, enabling facilities to choose hardware freely and consolidate multiple legacy systems into one platform. It offers high-performance multimodality image display and analysis with intuitive, customizable workflows that accelerate reporting, improve data visualization, and reduce manual steps from acquisition through interpretation, facilitating fast and accurate review of PET/CT, SPECT/CT, and PET/MR studies. Hermia’s comprehensive toolset includes optimized SPECT reconstruction for diverse procedures and radio-pharmaceuticals, a broad nuclear medicine processing toolkit for osteology, gastroenterology, nephrology, and endocrinology, and specialized modules for pneumology with lung function and SPECT V/Q quantification.